Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3

The role of lysyl oxidase (LOX) in prostate cancer remains controversial. Studies have shown that LOX may inhibit the progression of prostate cancer (PCa), whereas other studies demonstrate that LOX may act as a tumor activator in PCa. Here, we report that low LOX expression contributes to CRPC prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xuanrong, Shao, Yi, Wei, Wanqing, Shen, Haishan, Li, Yang, Chen, Yutong, Ma, Qianwang, Li, Hanlin, Yang, Zhao, Niu, Yuanjie, Shang, Zhiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734407/
https://www.ncbi.nlm.nih.gov/pubmed/35003355
http://dx.doi.org/10.7150/jca.61131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734407/
https://www.ncbi.nlm.nih.gov/pubmed/35003355
http://dx.doi.org/10.7150/jca.61131

Ejemplares similares